Global Dermatology Treatment Devices Market will cross USD 9,389.73 million by 2025. It was valued at USD 4,016.47 million in 2017. The market is growing at a CAGR of 11.3% in the forecast period 2018 to 2025

Market Segmentation: Global Dermatology Treatment Devices Market
• On the basis of type global dermatology treatment devices market is segmented into lasers, light therapy devices, cryotherapy devices, microdermabrasion devices, energy-based therapies devices and microneedling. In 2018, lasers segment is estimated to rule with 33.0% shares and will cross USD 3,195.33 million by 2025, rising at the CAGR of 11.8%. However, microneedling is expected to grow at the highest CAGR of 12.2% in the forecast period, and is expected to reach USD 885.34 million in 2025 from USD 354.15 million in 2017.
• Lasers are further sub segmented into CO2 laser, ER: YAG laser, ND: YAG laser, Q switch laser, and other laser devices. Light therapy devices are further sub segmented into intense pulsed light (IPL), LED light therapy, ultraviolet light therapy and infrared light therapy. Energy-based therapies devices are further sub segmented into radiofrequency (RF) devices, ultrasound technology device and microwave device.
• On the basis of application global dermatology treatment devices market is segmented into skin rejuvenation, hair removal, psoriasis, scar, skin resurfacing, skin lesion, warts & skin tags, pigmented and vascular, lesion removal, acne, tattoo removal, hyperhidrosis and others. In 2018, skin resurfacing segment is estimated to rule with 25.1% shares and will cross USD 2,485.38 million by 2025, rising at the highest CAGR of 12.1%.

Request For Sample- https://databridgemarketresearch.com/request-a-sample/?dbmr=global-dermatology-treatment-devices-market

Key Points: Global Dermatology Treatment Devices Market
Syneron Medical Ltd is going to dominate the global dermatology treatment devices market followed by Cutera, Inc., Valeant Pharmaceuticals International, Inc., Beijing Toplaser Technology Co, Ltd., Avita Medical, Biofrontera AG , Sciton Inc., Lumenis, Alma Lasers, Radiancy, Inc. among others.
• The Laser segment is dominating the global dermatology treatment devices market.
• The Lasers segment is expected to grow with the highest CAGR of 11.8% in the forecast period 2018 to 2025.
The global dermatology treatment devices market highly concentrated to a few big players and rest to local players who cater to domestic markets only.
Other players in this market include are
• Beijing Toplaser Technology Co, Ltd.,
• Avita Medical,
• Biofrontera AG ,
• Sciton Inc.,
• Lumenis,
• Alma Lasers,
• Radiancy, Inc.
• among others.
Syneron Medical Ltd:
Founded in 2000 and headquartered in Massachusetts, U.S. SYNERON MEDICAL LTD. is engaged in global non-surgical aesthetic device with a comprehensive product portfolio with footprints in global distribution. It provides various advance solutions for medical-aesthetic including improving the skin’s appearance, treatment of superficial benign vascular and pigmented lesions, body contouring, hair removal, wrinkle reduction, tattoo removal, the treatment of acne, leg veins and cellulite, women’s intimate health and others. Company’s products are entirely based on laser, ultrasound, and radiofrequency. The company‘s product line includes CO2RE, CO2RE Intima, GentleLase, and others.
In 2017 Syneron Medical Ltd. announced the acquisition by an affiliate of funds advised by Apax Partners. The company has a strong geographic presence across the globe. Some of the subsidiaries are Candela Corp(U.S.), Syneron China (China), Rakuto Bio Technologies Ltd. (Israel), TransPharma Medical Ltd.(Israel), Ultrashape Ltd.( Israel), Syneron Beauty, Inc. (Israel) and others.
Cutera Inc:
R
equest For TOC- https://databridgemarketresearch.com/toc/?dbmr=global-dermatology-treatment-devices-market
Valeant Pharmaceutical International Inc:
Valeant Pharmaceuticals International, Inc. was established in 1960 and headquartered in New Jersey, U.S. The company manufactures and supplies a wide range of pharmaceutical, medical device and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology and dermatology.
The company has subsidiaries worldwide. Some of them are Valeant Pharmaceuticals Ireland Limited (Ireland), Valeant China Inc. (China), Valeant Pharmaceuticals New Zealand Limited (New Zealand), Solta Medical (U.S), Obagi Medical (U.S) and many more. The company has strong geographic presence in U.S., Puerto Rico, China, Japan, Mexico, Poland, Russia, France, Germany, Egypt, Australia, United Kingdom and Brazil.

Inquiry Before Buying- https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-dermatology-treatment-devices-market
About Us:
Data bridge Market Research is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune. We ponder into the heterogeneous markets in accord with our client’s needs and scoop out the best possible solutions and detailed information about the market trends. Data Bridge delve into the markets across Asia, North America, South America, Africa to name few
Contact Us:
Data Bridge Market Research
Toll Free: +1-888-387-2818
Email - [email protected]